Skip to main content
Journal cover image

Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage.

Publication ,  Journal Article
Yurashevich, M; Rosser, M; Small, M; Grotegut, C; Kota, N; Toffaletti, J; Allen, T
Published in: Clin Appl Thromb Hemost
2023

AIM: This study aims to investigate the ability of fibrinogen and rotational thromboelastometry (ROTEM) parameters measured at obstetric hemorrhage protocol initiation to predict severe hemorrhage. METHODS: In this retrospective study we included patients whose hemorrhage was managed with an obstetric massive transfusion protocol. Fibrinogen and ROTEM parameters EXTEM clotting time (CT), clot formation time (CFT), alpha angle, A10, A20, lysis index 30 min after CT (LI30), FIBTEM A10, A20, were measured at initiation of the protocol with transfusion based on a predefined algorithm. Patients were grouped into either severe or nonsevere hemorrhage based on: peripartum fall in hemoglobin ≥4 g/dL, transfusion of ≥4 units of blood product, invasive procedures for hemorrhage control, intensive care unit admission, or death. RESULTS: Of the 155 patients included, 108 (70%) progressed to severe hemorrhage. Fibrinogen, EXTEM alpha angle, A10, A20, FIBTEM A10, A20 were significantly lower in the severe hemorrhage group while the CFT was significantly prolonged in the severe hemorrhage group. In univariate analysis, predicted progression to severe hemorrhage yielded areas under the receiver operating characteristic curve (95% confidence interval [CI]) of: fibrinogen: 0.683 (0.591-0.776), CFT: 0.671 (0.553, 0.789), EXTEM alpha angle: 0.690 (0.577-0.803), A10: 0.693 (0.570-0.815), A20: 0.678 (0.563-0.793), FIBTEM A10: 0.726 (0.605-0.847), and A20: 0.709 (0.594-0.824). In a multivariable model, fibrinogen was independently associated with severe hemorrhage (odds ratio [95% CI] = 1.037 [1.009-1.066]) for every 50 mg/dL decrease in fibrinogen drawn at obstetric hemorrhage massive transfusion protocol initiation. CONCLUSION: Both fibrinogen and ROTEM parameters measured at the initiation of an obstetric hemorrhage protocol are useful parameters for predicting severe hemorrhage.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Appl Thromb Hemost

DOI

EISSN

1938-2723

Publication Date

2023

Volume

29

Start / End Page

10760296231175089

Location

United States

Related Subject Headings

  • Thrombelastography
  • Retrospective Studies
  • Pregnancy
  • Humans
  • Hemostatics
  • Hemorrhage
  • Fibrinogen
  • Female
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yurashevich, M., Rosser, M., Small, M., Grotegut, C., Kota, N., Toffaletti, J., & Allen, T. (2023). Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage. Clin Appl Thromb Hemost, 29, 10760296231175088. https://doi.org/10.1177/10760296231175089
Yurashevich, Mary, Morgan Rosser, Maria Small, Chad Grotegut, Nancy Kota, John Toffaletti, and Terrence Allen. “Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage.Clin Appl Thromb Hemost 29 (2023): 10760296231175088. https://doi.org/10.1177/10760296231175089.
Yurashevich M, Rosser M, Small M, Grotegut C, Kota N, Toffaletti J, et al. Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage. Clin Appl Thromb Hemost. 2023;29:10760296231175088.
Yurashevich, Mary, et al. “Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage.Clin Appl Thromb Hemost, vol. 29, 2023, p. 10760296231175088. Pubmed, doi:10.1177/10760296231175089.
Yurashevich M, Rosser M, Small M, Grotegut C, Kota N, Toffaletti J, Allen T. Evaluating the Association Between Fibrinogen and Rotational Thromboelastometry and the Progression to Severe Obstetric Hemorrhage. Clin Appl Thromb Hemost. 2023;29:10760296231175088.
Journal cover image

Published In

Clin Appl Thromb Hemost

DOI

EISSN

1938-2723

Publication Date

2023

Volume

29

Start / End Page

10760296231175089

Location

United States

Related Subject Headings

  • Thrombelastography
  • Retrospective Studies
  • Pregnancy
  • Humans
  • Hemostatics
  • Hemorrhage
  • Fibrinogen
  • Female
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology